Spinal cord injury (SCI) leads to devastating and often permanent loss of movement and sensation, yet there are currently no effective therapies that restore function. This PhD project will explore new ways to protect and regenerate nerve cells after spinal cord injury by combining molecular biology, pharmacology, and gene therapy in translational models of central nervous system repair.
The work will focus on two key molecular pathways that have shown strong promise in pre-clinical studies of the visual system: axon organelle transport to support axon growth and regeneration, and NAD metabolism, a pathway that promotes neuronal survival by sustaining essential cellular functions. Together, these pathways may provide a powerful approach to protect neurons from secondary degeneration and promote long-range axon regeneration after injury.
This is a collaborative project between the Eva Lab at King’s College London, Wolfson SPaRC (Sensory, Pain and Regeneration Centre) and the Williams Lab at Centre for Eye Research Australia, a world-leading group in ocular neuroprotection. The project will integrate the complementary expertise of both teams, combining pharmacological neuroprotection developed in the Williams lab with AAV-based gene therapy and axon regeneration strategies pioneered in the Eva lab.
Students will be trained across the full translational spectrum, from neuronal cell biology and gene therapy design, through in vitro mechanistic assays, to in vivo models of spinal cord injury for testing neuroprotective and regenerative outcomes. Techniques will include viral vector design, immunocytochemistry, confocal microscopy, tissue processing and imaging, quantitative gene and protein analyses, and behavioural and histological assessment of neural recovery. These studies will identify how two key pathways interact to protect and regenerate injured neurons, providing mechanistic insight and a platform for future therapy development.
The successful candidate will join a vibrant neuroscience community within Wolfson SPaRC, working alongside leading regeneration and pain researchers and benefiting from the extensive postgraduate training programmes at King’s College London. Regular meetings with the Williams lab will provide additional supervision, international collaboration experience, and opportunities to develop specialist skills in data analysis and neuroprotective pathway biology.
We are looking for a motivated student with a strong interest in neurobiology, molecular and cellular neuroscience, or regenerative medicine. The project will suit someone who enjoys a balance of molecular benchwork and experimental models, and who is keen to contribute to translational science with real clinical potential.
This is an exciting opportunity to be part of a collaborative, multidisciplinary project combining pharmacology, gene therapy, and cutting-edge neuroscience to discover new therapeutic strategies for spinal cord repair.
Applicants should have (or be expected to obtain) a bachelor’s degree with 2:1 honours (or Overseas equivalent). A 2:2 degree may be considered only where applicants also offer a master’s with Merit.
1 fully funded 3.5 year PhD, funded by Spinal Research.
The award consists of the following elements:
(a) Tuition Fees for the Host University at the home rate
(b) A stipend for the Student at the relevant rate
(c) The cost of consumable laboratory materials
(d) Travel expenses for the Student up to a total of £1,000
1st supervisor: Dr Richard Eva - richard.eva@kcl.ac.uk
2nd supervisor: Professor Elizabeth Bradbury - elizabeth.bradbury@kcl.ac.uk
Applicants must complete and submit an online admissions application, via the admissions portal by midnight (23:59 GMT), 22nd October 2025.
On the ‘Choosing a programme’ page, please select Psychosis Studies Research MPhil/PhD (Full-Time). More information on the department and the programme is available at the departmental prospectus page here: https://www.kcl.ac.uk/academic-psychiatry/about/departments/psychosis
Applicants must complete and submit an online admissions application, via the admissions portal by midnight (23:59 GMT), 10th November 2025. On the ‘Choosing a programme’ page, please select Wolfson SPaRC Research MPhil/PhD (Full-time). More information on the department and the programme is available at the departmental prospectus page here: https://www.kcl.ac.uk/neuroscience/about/departments/wolfson
In your application, you will be asked to include:
· Academic Transcripts - where applicable, academic transcripts must be submitted with the online admissions application
· Details of your qualifications - you will need to attach copies
· Details of previous employment - please include your CV
· A personal statement describing your interests and why you wish to apply for this project. Please include this as an attachment rather than using the text box.
· Academic References – all admissions applications require one supporting reference. If the applicant is relying on their referees to submit a reference directly to the College after they have submitted their admissions application, then the applicant must ensure that (1) their chosen referee is made aware of the funding deadline (i.e. 7 days from application deadline) and (2) that the reference needs to be sent from an institutional email address.
In the Funding section, please tick box 5 and include the following reference: (RE-IoPPN-Spinal Research-25). References must be received by the deadline for the applicant to be eligible. Only shortlisted applicants will be contacted.
You are welcome to email Richard Eva - richard.eva@kcl.ac.uk - for more information regarding the project and studentship. If you have any queries regarding the application process, please contact the Education support team at ioppn.pgr@kcl.ac.uk.
References should be received by the deadline for the applicant to be eligible, however please get in touch if you have any issues obtaining your reference, and we encourage you to still apply. Only shortlisted applicants will be contacted.
Home candidates only
...